Compugen | CGEN - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Arca Biopharma USD -29.58M 694K 2025-12
aTyr Pharma USD -25.75M 6.22M 2025-09
Bio Path USD -4.6M 1.74M 2025-06
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Cara Therapeutics USD -4.91M 3.17M 2025-03
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD 56.84M 63.78M 2025-12
Immunic USD -21.38M 8.2M 2024-06
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
Minerva Neurosciences USD 22.51M 30.74M 2024-09
RedHill Biopharma USD -1.54M 12M 2024-06
TherapeuticsMD USD -1.05M 241K 2024-06